MALACRIDA ALESSIO
Pubblicazioni
Fabbro, V., Malacrida, A., Iseppon, F., Tarasiuk, O., Pero, M., Bartolini, F., et al. (2024). PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES. In Proceedings of the 34th National Conference of the Italian Group for the Study of Neuromorphology“Gruppo Italiano per lo Studio della Neuromorfologia” (pp.15-15). PAGEPress, Pavia, Italy. Dettaglio
Tarasiuk, O., Molteni, L., Malacrida, A., Nicolini, G. (2024). The Role of NMNAT2/SARM1 in Neuropathy Development. BIOLOGY, 13(1) [10.3390/biology13010061]. Dettaglio
Cavalloro, V., Marchesi, N., Linciano, P., Rossi, D., Campagnoli, L., Fossati, A., et al. (2024). Neurodegeneration: can metabolites from Eremurus persicus help?. FRONTIERS IN PHARMACOLOGY, 15, 1-13 [10.3389/fphar.2024.1309766]. Dettaglio
Rivara, M., Nicolini, G., Malacrida, A., Re, F., Incerti, M., Russo, G., et al. (2024). New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma. RESULTS IN CHEMISTRY, 9(July 2024) [10.1016/j.rechem.2024.101645]. Dettaglio
Malacrida, A., Tarasiuk, O., Rodriguez-Menendez, V., Stanga, S., Pero, M., Bartolini, F., et al. (2024). Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction. In Abstracts of the Fourteenth Annual Meeting of the Associazione italiana per lo studio del Sistema Nervoso Periferico (ASNP), 30 May – 1 June 2024, Trieste, Italy (pp.34-35). Wiley [10.1111/jns.12627]. Dettaglio